Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
Applying to Ohio State University Comprehensive Cancer Center · Columbus, Ohio
Answer a few short questions to share with the research team.